Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Published on by Neuroscientists

Dr. Ketan Bulsara | Cellular Neuroscience | Excellence in Neuroscience Research Award

Dr. Ketan Bulsara, University of Connecticut, United States.

Dr. Ketan Ramanlal Bulsara is a distinguished neurosurgeon, educator, and administrator whose career has been defined by excellence in academic leadership, innovative research, and patient-centered surgical advancements. With a strong foundation in medical education and training, he has held prestigious positions at leading institutions, making significant contributions to the fields of cerebrovascular and skull base surgery. His work in neurosurgical education, healthcare policy, and perioperative quality improvement continues to influence the next generation of medical professionals.

Profile

Google Scholar

 

🎓 Early Academic Pursuits: The Foundation of Excellence

Dr. Ketan Ramanlal Bulsara’s journey into the world of neurosurgery began with a strong academic foundation. He earned his Bachelor of Science in Biology and Neuroscience, graduating Magna Cum Laude from Davidson College in 1992. His passion for medicine led him to Duke University School of Medicine, where he earned his Medical Degree with Honors in 1996. Committed to mastering his craft, Dr. Bulsara underwent rigorous neurosurgical training at Duke University Medical Center, progressing through internship, residency, and chief residency roles. His dedication to specialized knowledge took him to the University of Iowa for a fellowship in Transoral Surgery and later to Duke’s Neurovascular Program for an advanced Endovascular Fellowship, earning CAST certification by the Senior Neurological Society.

🎉 Professional Endeavors: Pioneering Neurosurgical Excellence

Dr. Bulsara has held esteemed academic and leadership positions throughout his career. Beginning as an Assistant Professor at the University of Missouri, he quickly ascended to directorship roles at Yale University, where he led Neuroendovascular and Skull Base Surgery Programs. His expertise and leadership took him to UConn Health, where he has served as Professor and Chief of Neurosurgery since 2017. As Program Director of UConn’s Neurosurgery Residency Training Program and Director of Operating Room Quality, he has been instrumental in shaping the next generation of neurosurgeons. His administrative impact extended further when he was appointed Interim Inaugural Chairman of UConn’s Department of Neurosurgery in 2024.

📚 Contributions and Research Focus: Advancing Neurosurgical Innovation

Throughout his career, Dr. Bulsara has been at the forefront of neurosurgical research, focusing on cerebrovascular and skull base surgery, neuroendovascular techniques, and perioperative advancements. His tenure at Yale and UConn Health has been marked by groundbreaking contributions to neurosurgical methodologies, patient safety protocols, and cutting-edge surgical interventions. With a keen interest in medical policy and administration, he also serves as Chair of the UConn Health/University of Connecticut Dean’s Task Force on Coding and Documentation, ensuring optimal standards in medical practice.

🏆 Accolades and Recognition: A Trailblazer’s Achievements

Dr. Bulsara’s exemplary work has earned him widespread recognition in academic, clinical, and administrative spheres. His leadership has been pivotal in strengthening neurosurgical departments and residency programs, earning respect from peers and students alike. His continued commitment to excellence led him to pursue an Executive MBA at Yale School of Management, which he completed in 2017, equipping him with advanced skills in healthcare management and strategic planning. Furthering his multidisciplinary expertise, he embarked on a legal education at the University of Connecticut School of Law in 2024, highlighting his commitment to integrating medicine, business, and law for the betterment of healthcare.

💡 Impact and Influence: Shaping the Future of Neurosurgery

Dr. Bulsara’s influence extends far beyond the operating room. As a mentor, he has trained and guided numerous neurosurgeons, instilling in them the values of precision, innovation, and patient-centered care. His research and administrative contributions have shaped hospital policies and perioperative strategies, leading to improved surgical outcomes and enhanced healthcare delivery systems. His work in academic leadership continues to bridge the gap between medical practice, research, and education.

 

Publication

  • Spinal axon regeneration evoked by replacing two growth cone proteins in adult neurons – HM Bomze, KR Bulsara, BJ Iskandar, P Caroni, JH Pate Skene (2001)

 

  • Longitudinal molecular trajectories of diffuse glioma in adults – FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, et al. (2019)

 

  • Glioma progression is shaped by genetic evolution and microenvironment interactions – FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, et al. (2022)

 

  • Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 guidelines for the early… – EE Smith, DM Kent, KR Bulsara, LY Leung, JH Lichtman, MJ Reeves, et al. (2018)

 

  • Perioperative complications in transforaminal lumbar interbody fusion versus anterior–posterior reconstruction for lumbar disc degeneration and instability – AT Villavicencio, S Burneikiene, KR Bulsara, JJ Thramann (2006)

 

  • Vessel wall magnetic resonance imaging identifies the site of rupture in patients with multiple intracranial aneurysms: proof of principle – CC Matouk, DM Mandell, M Günel, KR Bulsara, A Malhotra, R Hebert, et al. (2013)

 

  • Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein—2 – AT Villavicencio, S Burneikiene, EL Nelson, KR Bulsara, M Favors, et al. (2005)

 

  • Laminectomy versus percutaneous electrode placement for spinal cord stimulation – AT Villavicencio, JC Leveque, L Rubin, K Bulsara, JP Gorecki (2000)

 

  • Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee – M Mokin, SA Ansari, RA McTaggart, KR Bulsara, M Goyal, M Chen, et al. (2019)

 

  • Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy – SM Nimjee, CJ Powers, KR Bulsara (2006)

 

💪 Conclusion

A visionary in neurosurgery, Dr. Bulsara’s impact transcends surgical practice, reaching into medical education, research, and healthcare administration. His multidisciplinary approach—combining medicine, business, and law—positions him as a leader in shaping the future of healthcare. His commitment to innovation and excellence ensures that his contributions will continue to elevate neurosurgical standards and inspire future generations of medical professionals.

 

 

 

Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Daša Zupančič | Cellular Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Daša Zupančič, Faculty of Medicine, University of Ljubljana, Slovenia.

Daša Zupančič is a distinguished academic and researcher specializing in cell biology, urothelial pathology, and medical education. Her extensive contributions to scientific research, particularly in the field of urothelial repair and cancer transformation, have earned her recognition, including the EMBO award. She has played a crucial role in mentoring and teaching, guiding future generations of researchers and medical professionals.

Profile

Orcid

✨ Early Academic Pursuits ✨

Daša Zupančič embarked on her academic journey with an unwavering passion for cell biology and medicine. She earned her Master’s degree in 2002 from the University of Ljubljana, Faculty of Medicine, where she meticulously explored cellular and molecular biological changes in the rat bladder urothelium following cyclophosphamide exposure. This formative research laid the foundation for her Ph.D., which she successfully completed in 2006, investigating the protective role of melatonin in urothelial injury and repair. Her dedication to advancing biomedical knowledge was evident from the very beginning of her scholarly career.

🎓 Professional Endeavors 🎓

Since 2006, Daša Zupančič has been an esteemed Associate Professor at the University of Ljubljana, Faculty of Medicine, Institute of Cell Biology. Prior to this, she gained valuable experience as a Young Researcher and Teaching Assistant from 1999 to 2006. Her extensive expertise and commitment to education have made her an integral part of the institution, where she continuously fosters scientific curiosity and excellence among students and colleagues alike.

🎡 Contributions and Research Focus 🎡

Throughout her career, Daša Zupančič has dedicated her research to understanding cellular mechanisms in urothelial biology and pathology. Her investigations into cyclophosphamide-induced urothelial injury, melatonin’s protective effects, and retinoid signaling pathways in urothelial cancer transformation have provided valuable insights into cellular repair processes. Her work extends beyond laboratory research, influencing the medical community’s approach to urothelial diseases and potential therapeutic advancements.

🏆 Accolades and Recognition 🏆

Her exceptional contributions to biomedical research have been recognized on multiple platforms. In 2017, she was honored with the prestigious EMBO award for her short-term scholarship project on the role of the retinoid signaling pathway in urothelial cancer transformation. This recognition underscores her significant impact on the scientific community and highlights her pioneering approach to understanding cancer pathophysiology.

👨‍🎓 Impact and Influence 👨‍🎓

A dedicated mentor, Daša Zupančič has guided numerous students towards academic excellence. Between 2014 and 2025, she has successfully mentored four master’s students and is currently supervising two more. In addition, she has overseen the research endeavors of four Ph.D. candidates, with one having successfully defended their dissertation in 2023 and another expected to graduate in 2025. Her mentorship has shaped the next generation of biomedical researchers, fostering a culture of rigorous inquiry and scientific discovery.

📚 Legacy and Future Contributions 📚

Beyond her research, Daša Zupančič plays a pivotal role in academia through her extensive teaching engagements. Since 2000, she has been a cornerstone of education at the University of Ljubljana, contributing to multiple faculties, including Medicine, Biotechnical Sciences, Health Sciences, and Pharmacy. She teaches a range of graduate and doctoral courses, covering essential subjects such as Medical Cell Biology, Immunology, and Research in Medicine. Her dedication to education ensures that her knowledge and expertise continue to shape the minds of aspiring medical professionals and researchers for years to come.

Publication

  • Vitamin A‐Enriched Diet Increases Urothelial Cell Proliferation by Upregulating Itga3 and Areg After Cyclophosphamide‐Induced Injury in Mice
    Authors: Brina Dragar, Simona Kranjc Brezar, Maja Čemažar, Tanja Jesenko, Rok Romih, Mateja Erdani Kreft, Tadeja Kuret, Daša Zupančič
    Year: 2025

 

  • Selective Targeting of Lectins and Their Macropinocytosis in Urothelial Tumours: Translation from in vitro to ex vivo
    Authors: Nataša Resnik, Tanja Višnjar, Tomaž Smrkolj, Mateja Erdani Kreft, Rok Romih, Daša Zupančič
    Year: 2023

 

  • Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis
    Authors: Daša Zupančič, Peter Veranič
    Year: 2022

 

  • Transmission Electron Microscopy Demonstration of Reduced Endothelial Glycocalyx in Severe Preeclampsia
    Authors: Mugerli S, Zupančič D, Rok Romih, Lučovnik M
    Year: 2022

 

  • Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects
    Authors: Larisa Tratnjek, Jera Jeruc, Rok Romih, Daša Zupančič
    Year: 2021

 

  • Immunohistochemistry as a Paramount Tool in Research of Normal Urothelium, Bladder Cancer and Bladder Pain Syndrome
    Authors: Daša Zupančič, Rok Romih
    Year: 2021

 

  • Combined Lectin- and Immuno-Histochemistry (CLIH) for Applications in Cell Biology and Cancer Diagnosis: Analysis of Human Urothelial Carcinomas
    Authors: Daša Zupančič
    Year: 2020

 

  • Vitamin A Rich Diet Diminishes Early Urothelial Carcinogenesis by Altering Retinoic Acid Signaling
    Authors: Daša Zupančič, Jelena Korać-Prlić, Mateja Erdani Kreft, Lucija Franković, Katarina Vilović, Jera Jeruc, Rok Romih, Janoš Terzić
    Year: 2020

 

  • Lectins as Possible Tools for Improved Urinary Bladder Cancer Management
    Authors: Daša Zupančič
    Year: 2019

 

  • Co-Culturing Porcine Normal Urothelial Cells, Urinary Bladder Fibroblasts and Smooth Muscle Cells for Tissue Engineering Research
    Authors: Daša Zupančič
    Year: 2018

 

🌟 Conclusion 🌟

With a career dedicated to pioneering research, impactful mentorship, and transformative education, Daša Zupančič continues to leave a lasting legacy in the scientific and academic communities. Her work not only enhances understanding of urothelial biology but also inspires innovation and discovery among young scientists. As she continues her academic and research endeavors, her influence on the field will undoubtedly grow, shaping the future of biomedical sciences.

 

Jeffrey Holt | Hearing and Sensory Transduction | Lifetime achievement Award

Published on by Neuroscientists

Prof. Jeffrey Holt | Hearing and Sensory Transduction | Lifetime achievement Award

Prof. Jeffrey Holt,  Harvard Medical School / Boston Children’s Hospital, United States.

Dr. Jeffrey R. Holt is a distinguished scientist whose groundbreaking contributions to auditory neuroscience and inner ear physiology have significantly advanced the field of otolaryngology. Currently serving as a Professor of Otolaryngology and Neurology at Boston Children’s Hospital and Harvard Medical School, Dr. Holt’s career is marked by an unwavering commitment to understanding the molecular and physiological mechanisms underlying hearing and balance disorders.

Profile

Google Scholar

 

Early Academic Pursuits 🎓

Born in Buffalo, NY, Dr. Holt’s passion for science was evident early in his academic journey. He earned his Bachelor of Science degree in Biology from Wofford College in 1986, laying a strong foundation in the life sciences. His quest for knowledge led him to the University of Rochester, where he pursued a Master’s degree in Physiology in 1992, followed by a Ph.D. in Physiology in 1995. His doctoral research provided deep insights into the intricate workings of sensory physiology, setting the stage for his future research endeavors in auditory neuroscience.

Professional Endeavors and Leadership 👩‍💼

Following his Ph.D., Dr. Holt embarked on postdoctoral training at Harvard Medical School, Massachusetts General Hospital, and the Howard Hughes Medical Institute. His extensive training in neurobiology enabled him to transition into academic roles, beginning as an Instructor in Neurobiology at Harvard Medical School and Massachusetts General Hospital from 1999 to 2001. He later joined the University of Virginia as an Assistant Professor of Neuroscience, where he progressed to Associate Professor before returning to Harvard in 2011. Since 2016, he has held the esteemed position of Professor of Otolaryngology at Boston Children’s Hospital and Harvard Medical School, as well as a faculty affiliation with the Harvard-MIT Health Sciences and Technology (HST) program.

Contributions and Research Focus 🌍

Dr. Holt’s pioneering research has been instrumental in decoding the molecular basis of hearing and balance disorders. His work focuses on sensory hair cells of the inner ear, aiming to uncover the genetic and physiological mechanisms that contribute to hearing loss. His studies have explored ion channel function, hair cell mechanotransduction, and gene therapy approaches for hereditary deafness. His innovative research has opened new avenues for therapeutic interventions, including the development of gene therapies targeting Usher syndrome and other genetic hearing disorders.

Accolades and Recognition 🏆

Throughout his career, Dr. Holt has been widely recognized for his contributions to auditory science. He has played key leadership roles in prestigious scientific organizations, serving as Chair of the Usher Syndrome Society Scientific Advisory Committee and Co-Chair of major international conferences such as the Keystone Conference on Sensory Systems and the New York Academy of Sciences Meeting. His service on various NIH and NIDCD advisory committees reflects his influence in shaping national research priorities in hearing and balance disorders.

Impact and Influence on Scientific Community 🌐

Dr. Holt’s impact extends beyond research, as he has been a dedicated mentor and educator throughout his career. He has guided numerous graduate students and postdoctoral fellows, serving on thesis and qualifying exam committees at Harvard Medical School. As a course director and research mentor, he has played a crucial role in training the next generation of auditory neuroscientists. His leadership in academic and scientific communities has helped bridge the gap between fundamental research and clinical applications in hearing restoration.

Legacy and Future Contributions 💪

With a legacy rooted in groundbreaking discoveries and scientific leadership, Dr. Holt continues to push the boundaries of auditory neuroscience. His ongoing research in gene therapy for hereditary deafness holds the promise of transforming lives through novel treatments for hearing loss. As a visionary in the field, his work is set to inspire future advancements in otolaryngology, offering hope to millions affected by hearing and balance disorders worldwide. His dedication to research, education, and clinical impact ensures that his contributions will leave a lasting imprint on auditory science for generations to come.

 

Publication

  • TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells
    Authors: DP Corey, J García-Añoveros, JR Holt, KY Kwan, SY Lin, MA Vollrath, …
    Year: 2004

 

  • Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
    Authors: X Gao, Y Tao, V Lamas, M Huang, WH Yeh, B Pan, YJ Hu, JH Hu, …
    Year: 2018

 

  • Mechanotransduction in mouse inner ear hair cells requires transmembrane channel–like genes
    Authors: Y Kawashima, GSG Géléoc, K Kurima, V Labay, A Lelli, Y Asai, …
    Year: 2011

 

  • TMC1 and TMC2 are components of the mechanotransduction channel in hair cells of the mammalian inner ear
    Authors: B Pan, GS Géléoc, Y Asai, GC Horwitz, K Kurima, K Ishikawa, …
    Year: 2013

 

  • Continuous evolution of base editors with expanded target compatibility and improved activity
    Authors: BW Thuronyi, LW Koblan, JM Levy, WH Yeh, C Zheng, GA Newby, …
    Year: 2019

 

  • Differential distribution of stem cells in the auditory and vestibular organs of the inner ear
    Authors: K Oshima, CM Grimm, CE Corrales, P Senn, R Martinez Monedero, …
    Year: 2007

 

  • A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells
    Authors: JR Holt, SKH Gillespie, DW Provance, K Shah, KM Shokat, DP Corey, …
    Year: 2002

 

  • A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear
    Authors: LD Landegger, B Pan, C Askew, SJ Wassmer, SD Gluck, A Galvin, …
    Year: 2017

 

  • Calcium imaging of single stereocilia in hair cells: localization of transduction channels at both ends of tip links
    Authors: W Denk, JR Holt, GMG Shepherd, DP Corey
    Year: 1995

 

  • TMC1 forms the pore of mechanosensory transduction channels in vertebrate inner ear hair cells
    Authors: B Pan, N Akyuz, XP Liu, Y Asai, C Nist-Lund, K Kurima, BH Derfler, …
    Year: 2018

 

Conclusion 🎯

Dr. Holt’s contributions to auditory neuroscience have revolutionized the field, bridging fundamental research with clinical applications. His groundbreaking work in gene therapy holds immense potential for treating hereditary hearing disorders, making a profound impact on global healthcare. As a researcher, educator, and leader, his legacy will continue to inspire innovation in otolaryngology and improve the lives of individuals affected by hearing and balance impairments for generations to come.

 

Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Pongrama Ramasoota | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.

Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.

 

Profile

Scopus

 

🎓 Early Academic Pursuits

Pongrama Ramasoota’s journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.

🏥 Professional Endeavors

As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.

🦠 Contributions and Research Focus

Dr. Ramasoota’s contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.

🏆 Accolades and Recognition

Dr. Ramasoota’s contributions to science have been recognized with numerous prestigious awards. He was honored as Thailand’s Outstanding Researcher in 2020 and named Thailand’s Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventors’ Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.

🌍 Impact and Influence

With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasoota’s research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.

📚 Legacy and Future Contributions

Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.

Publication

  1. Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
    Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
    Year: 2024

 

  1. Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
    Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
    Year: 2024

 

  1. Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
    Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
    Year: 2024

 

  1. Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
    Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
    Year: 2023

 

  1. Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
    Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
    Year: 2023

 

  1. Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
    Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
    Year: 2022

 

  1. Title: Spread of a Novel Indian Ocean Lineage Carrying E1‐K211E/E2‐V264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
    Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
    Year: 2022

 

🎯 Conclusion

Dr. Ramasoota’s work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.